Review article · 2025 · Open access

Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma

Alaa Zam, Nadia Rouatbi, Adam Alexander Walters, Khuloud T. Al‐Jamal

Advanced Drug Delivery Reviews, 229, 115759 · Published 11 December 2025 · DOI 10.1016/j.addr.2025.115759

Open full textCite this paper

In brief

“Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma” is a 2025 review article by Alaa Zam and 3 co-authors, published in Advanced Drug Delivery Reviews. OpenAlex counts 14 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Advanced Drug Delivery Reviews.

Citations
14
Most cited in
2026 (14)
Field-weighted impact
0.99
References
245
Authors
4

Abstract

Glioblastoma (GBM) is the most aggressive and treatment-resistant primary brain tumor in adults. Conventional therapies offer limited benefit due to the tumor's heterogeneity, invasive nature, and the presence of the blood-brain barrier, which restricts therapeutic access. Nucleic acid (NA)-based therapies, including small interfering RNA, microRNA, antisense oligonucleotides, splice-switching oligonucleotides, and CRISPR-based systems, have emerged as promising tools to modulate oncogenic pathways and overcome resistance mechanisms at the genetic level. However, effective delivery remains the primary challenge in translating these therapies into clinical success. This review examines the current landscape of NA-based strategies for GBM, with a focus on innovative delivery systems designed to navigate biological barriers and enhance therapeutic precision. We highlight clinical progress made with nanocarrier platforms such as liposomes, lipid nanoparticles, and exosome-based systems, and evaluate their safety, specificity, and delivery efficiency. Additionally, we discuss the most promising preclinical advances, including multifunctional, targeted, and stimuli-responsive carriers, that demonstrate strong potential for clinical translation. Our analysis underscores that the therapeutic efficacy of NA approaches in GBM is inseparable from the sophistication of their delivery platforms. Moving forward, the integration of rationally designed carriers with gene-targeted payloads holds the key to unlocking the full potential of precision medicine in GBM.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zam, A., Rouatbi, N., Walters, A. A., & Al‐Jamal, K. T. (2025). Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma. Advanced Drug Delivery Reviews, 229, 115759. https://doi.org/10.1016/j.addr.2025.115759

MLA 9

Zam, Alaa, et al. “Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma.” Advanced Drug Delivery Reviews, vol. 229, 2025, p. 115759. https://doi.org/10.1016/j.addr.2025.115759.

Chicago

Zam, Alaa, Nadia Rouatbi, Adam Alexander Walters, and Khuloud T. Al‐Jamal. 2025. “Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma.” Advanced Drug Delivery Reviews 229: 115759. https://doi.org/10.1016/j.addr.2025.115759.

Harvard

Zam, A. et al. (2025) ‘Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma’, Advanced Drug Delivery Reviews, 229, p. 115759. doi:10.1016/j.addr.2025.115759.

IEEE

A. Zam, N. Rouatbi, A. A. Walters, and K. T. Al‐Jamal, “Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma,” Advanced Drug Delivery Reviews, vol. 229, p. 115759, 2025, doi: 10.1016/j.addr.2025.115759.

BibTeX

@article{zam2025overcoming,
  title     = {{Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma}},
  author    = {Zam, Alaa and Rouatbi, Nadia and Walters, Adam Alexander and Al‐Jamal, Khuloud T.},
  journal   = {Advanced Drug Delivery Reviews},
  year      = {2025},
  volume    = {229},
  pages     = {115759},
  doi       = {10.1016/j.addr.2025.115759},
  url       = {https://doi.org/10.1016/j.addr.2025.115759}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • glioblastoma
  • nucleic acid therapeutics
  • gene delivery
  • blood-brain barrier
  • siRNA
  • microRNA
  • antisense oligonucleotides
  • splice-switching oligonucleotides

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zam, A., Rouatbi, N., Walters, A. A., & Al‐Jamal, K. T. (2025). Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma. Advanced Drug Delivery Reviews, 229, 115759. https://doi.org/10.1016/j.addr.2025.115759

How many times has this paper been cited?

14 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Drug Delivery Reviews: sign in and open the full text from this page.

Who wrote this paper?

Alaa Zam, Nadia Rouatbi, Adam Alexander Walters, Khuloud T. Al‐Jamal.

What is the DOI of this paper?

10.1016/j.addr.2025.115759, permanently at https://doi.org/10.1016/j.addr.2025.115759. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.